RecruitingGynecologic CancerChemotherapy EffectChemo-brain
Improve Cancer-related Cognitive Impairment
Eligible age
18–90 yrs
Accepts
Women
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary approach with patients undergoing assessments by our neurocognitive team.
Sponsor: University of Alabama at Birmingham
You may qualify if…
- ✓ newly diagnosed gynecologic malignancy (uterine, cervical, ovarian, primary peritoneal, vulvar, or vaginal) and undergoing chemotherapy
- ✓ own a smartphone or tablet with ability to download cognitive training application
- ✓ and age \>21 years old
You may not qualify if…
- ✕ medical diagnosis of dementia
- ✕ significant underlying mental diagnoses for which they are on more than 1 medication for (patients with depression or anxiety on single-agent therapy will be able to participate
- ✕ age \<21
Where it's recruiting
Alabama
Birmingham
Source: ClinicalTrials.gov · NCT05864274 · last updated 2025-11-24